Background/Aims: Osterix (Osx), a key regulator of osteoblast differentiation and bone formation, has been recently reported to be associated with the progression of breast cancer. However, the precise roles of Osx in breast cancer remain unclear. Methods: Drug sensitivity of the cancer cells was assessed using an 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-Htetrazolium bromide (MTT) assay. Target genes were obtained by high-throughput Illumina sequencing and were confirmed in vitro and in vivo. Apoptosis was analysed by Hoechst staining and western blotting. A tissue microarray including 129 samples from breast cancer patients was used for immunohistochemistry (IHC) assays. Results: Overexpression of Osx decreased the chemosensitivity of breast cancer cells, while knockdown of Osx increased the chemosensitivity of breast cancer cells. In particular, we found that the decreased chemosensitivity effect was significantly associated with elevated expression of the polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14). Silencing of GALNT14 in Osx-overexpressed cells restored the decreased chemosensitivity. Conversely, overexpression of GALNT14 in Osxknockdown cells abrogated the increased chemosensitivity in breast cancer cells. In addition, we revealed that Osx decreased GALNT14-dependent chemosensitivity by enhancing antiapoptosis. GALNT14 expression exhibited a significant association with breast cancer stages as well as the disease-free survival (DFS) rate. Conclusion: Osx plays an important role in the chemosensitivity and inhibition of Osx expression may represent a therapeutic strategy to enhance the chemosensitivity of breast cancer.
Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14

Introduction
Breast cancer is the most common cancer in women [1] . In recent decades, worldwide cancer reports have shown a gradually increasing trend in developing countries and a continuously high breast cancer incidence in western countries [2] . Although early diagnosis, radical surgery and the development of adjuvant therapy have improved the prognosis of breast cancer patients, this disease remains a major problem worldwide [3] . For the treatment of breast cancer, chemotherapy is one of the most important approaches currently [4] [5] [6] . Doxorubicin (dox) and paclitaxel (pax) have been used as available anti-cancer agents to treat tumours [7] , including breast cancer [8] . However, one of the central challenges in breast cancer treatment with pax and dox is drug insensitivity, which leads to therapeutic failure. Thus, finding a novel way to improve the efficacy of chemotherapy among druginsensitive patients is imperative in breast cancer therapy [9] .
Osx, also known as SP7, was reported as a C2H2-type zinc-finger-containing transcription factor in 2002 [10] . Osx is a key regulator in osteoblast differentiation and maturation. Osx haploinsufficiency in mouse chondrocytes exhibited delayed growth of both trabecular and cortical bones [11] [12] [13] . Osx-null mice with the complete absence of intramembranous and endochondral bone formation died immediately after birth [14] . Recently, Dai et al. reported that Osx is involved in the metastasis of human breast cancers [15] . However, the precise roles of Osx in breast cancer remain unclear and need to be elucidated.
GALNT14 is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAcTs) protein family consisting of at least 20 members [16, 17] . Studies have shown that O-glycosylation and GALNT members play critical roles in various biological processes as well as in human disease development, including tumourigenesis [18] . For example, GALNT3 serves as an unfavourable prognostic marker in non-small cell lung cancer [19] . GALNT6 expression significantly correlates with tumour differentiation and predicts the prognosis in pancreatic cancer and breast cancer [20, 21] . GALNT6 and GALNT14 were found to be elevated in breast and gastric carcinomas [22] [23] [24] [25] [26] . Moreover, GALNT14 was also found to enhance tumour invasion and migration in breast cancer cells [27] . Recently, a singlenucleotide polymorphism in the GALNT14 gene was identified as an effective predictor of the response to chemotherapy in advanced hepatocellular carcinoma [28] .
In the present study, we demonstrated that overexpression of Osx decreased the chemosensitivity of breast cancer cells, and knockdown of Osx increased the chemosensitivity of breast cancer cells. Gene sequencing profiling revealed that Osx upregulated the expression of GALNT14. Moreover, we found that the decrease in chemosensitivity by Osx was partially due to the upregulation of GALNT14 and enhancement of anti-apoptosis in breast cancer cells. GALNT14 expression levels were significantly associated with clinical stage as well as the disease-free survival (DFS) rate. These findings suggest that inhibition of Osx expression may be a therapeutic strategy to improve the chemosensitivity of breast cancer.
Materials and Methods
Cell, chemicals and antibodies MDA-MB-231 cells with Osx stable overexpression and knockdown, as well as their corresponding control cells (231-OE6, OEC, 231-KD2, KDC), were previously established by our laboratory and were maintained in RPMI-1640 medium supplemented with 10% foetal bovine serum (FBS). MDA-MB-231 was purchased from American Type Culture Collection (ATCC, USA), cultured in the presence of 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in 5% CO 2 . Protease inhibitors were obtained from Roche Diagnostics (Mannheim, Germany). Dox and pax were purchased from Sigma Aldrich (St. Louis, MO, USA). The anti-Osx and anti-GALNT14 antibodies were purchased from Abcam (Cambridge, MA, USA) and Santa Cruz (Biotech, America), respectively. Antibodies against Bax and β-actin, as well as anti-rabbit and antimouse IgG, were obtained from Bioworld Technology (Minneapolis, MN, USA). The anti-Bcl-2 antibody was obtained from Proteintech Group (Biotech, America). Lipofectamine 2, 000 was purchased from Invitrogen (Carlsbad, CA, USA). The immunohistochemistry target retrieval solution and Hoechst 33258 were obtained from Beyotime Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry 
MTT assay
Cells were plated in 96-well plates with 8000 cells per well and adhered overnight. Next, cells were treated with dox (0, 1, 2, 4 µM) or pax (0, 5, 10, 15, 20 µM) for 24, 36 and 48 h, followed by the addition of 20 μl of MTT (5 mg/ml in PBS) to each well. After 4 h, the medium was removed, 150 μl of DMSO solution was added per well to dissolve the formazan crystals, and the absorption was measured at a wavelength of 492 nm.
Western blotting
Western blotting was performed as described previously [29] [30] [31] . First, RIPA buffer plus protease inhibitors were added to lyse cells, and then the protein samples were separated via SDS-PAGE, followed by transfer to a PVDF membrane and detection with the ECL reagent. The chemiluminescent signal was collected and analysed by Gelcap (Tanlon 5200). Index of Density (IOD) of each band was calculated as density×area. The value of the IOD ratio was calculated as follows: IOD ratio = IOD of Osx, GALNT14, Bcl-2 or Bax / IOD of β-actin. The fold change (IOD ratio of KD) or the OE/IOD ratio of the control was presented above each blot.
RNA isolation and Real-time PCR
The total RNA of the cell samples was extracted using 1 ml of RNAiso plus according to the manufacturer's protocol. cDNA was synthesized from 1 μg of total RNA using the PrimeScript RT reagent kit in reverse transcription reactions. According to the manufacturer's instructions, FastStart Universal SYBR Green Master using a Roche LightCycler® 96 RealTime PCR System was used to assess the mRNA levels. Expression values were normalized to the value for β-actin. The relative quantity was reckoned using the 2 -∆∆Ct method. Primers used for amplification were listed in Table 1 .
Animal xenograft model
This study was approved by the Animal Care and Use Committee of Nanjing Medical University. The nude mice were maintained in a controlled environment (temperature 20-25°C, humidity 50-80%, illumination at 12 h light/12 h dark). The mice were fed standard laboratory food and water ad libitum for at least 1 week for environmental adjustment before the study. The cell aliquots (100 μl) were mixed with matrigel, and the mixture was immediately engrafted into the fourth fat pad of 6-week-old female BALB/c-nu/nu mice (n=8 each group). Six weeks later, all the animals were sacrificed, and the tumour samples were formalin fixed and paraffin embedded for immunohistochemical analysis.
Immunohistochemistry (IHC)
The formalin-fixed, paraffin-embedded primary breast cancer tissues were sectioned (5 μm) and baked at 65°C overnight. Endogenous peroxidase activity was blocked with peroxidase blocking reagent (0.03%
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Cellular Physiology and Biochemistry hydrogen peroxide) for 10 min. The primary antibodies were added, and then the tissues were incubated at 4°C overnight, followed by incubation with the secondary antibody for 20 min. Diaminobenzidine tetrahydrochloride (DAB) substrate buffer mixed with DAB chromogen was added for 1-2 min. Between these steps, the slides were rinsed in TBS for 2 min three times. Sections were then counterstained with haematoxylin, dehydrated, and mounted. Three pathologists evaluated and scored the staining levels of Osx and GALNT14 based on the intensity of staining (1= low; 2= middle; 3= high) and percentage of stained cells (0= 0% stained; 1= 1%-49% stained; 2= 50%-100% stained). A multiplied score (intensity score × percentage score) lower than 2 was considered low expression, and scores of 2-6 were considered high expression.
Hoechst staining
Cells were seeded in 24-well plates and were allowed to adhere overnight. After dox or pax treatment for 36 h, the medium was removed, and the cells were washed three times with cold PBS and then were fixed with 4% formaldehyde for 10 min at room temperature. Next, the cells were washed three times with cold PBS and were stained with Hoechst 33258 for 5 min. After staining, the cells were rinsed with cold PBS and were examined under a fluorescence microscope. Four different fields were analysed, and the apoptosis rate was reckoned as the ratio of the number of apoptotic cells to the total number of cells (expressed as a percentage).
Patients and tissue microarray
The paraffin-embedded tissue samples were obtained from the Affiliated Yixing Hospital of Jiangsu University, Yixing, China. Written informed consent was obtained from each patient, and the study was approved by the Institute Research Ethics Committee at the Affiliated Yixing Hospital of Jiangsu University. No patient received any other therapy before surgery. All tumour samples were acquired at the time of operation and were fixed with paraformaldehyde (4%). Tissue microarray including 129 representative paraffin-embedded tissue samples from 129 patients with breast cancer were obtained from Shanghai Biochip Center (Shanghai, China).
Statistical Analysis
The data were presented as the means ± SD and were analysed with SPSS 17.0. Statistical significance was determined using T test to evaluate the differences among groups. A value of P<0.05 was deemed to indicate statistical significance.
Statement
All experiments were performed in accordance with approved guidelines and regulations of the Nanjing Medical University.
Results
Osx decreases the chemosensitivity of breast cancer cells
We have examined the expression of Osx in various breast cancer cell lines by western blot analysis and found that Osx exhibited moderate expression in MDA-MB-231 cells (data not shown). MDA-MB-231 stable cell lines with Osx overexpression or knockdown have been constructed to explore the roles of Osx in breast cancer cells. To evaluate the effect of Osx on the chemosensitivity of breast cancer cells, MDA-MB-231 cells with Osx stable transfection or knockdown, as well as their corresponding control cells (231-OE6, 231-OEC, 231-KD2, 231-KDC), were treated with dox or pax, respectively. Next, the growth inhibition rate was determined by the MTT assay. The results showed that overexpression of Osx significantly reduced the growth inhibition rates of MDA-MB-231 cells, accompanied by an increased IC50. However, knockdown of Osx significantly increased the growth inhibition rates of MDA-MB-231 cells, accompanied by a decreased IC50 (Fig. 1a-d) . Together, these data suggest that Osx may be an important regulator of chemosensitivity in breast cancer cells.
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GALNT14 is a target gene of Osx
To explore the mechanism by which Osx decreases the chemosensitivity of breast cancer cells, RNA samples extracted from 231-OE6 and 231-OEC cells were subjected to high-throughput Illumina sequencing. Fig. 2a shows the heatmap analysis of differentially expressed genes between 231-OE6 and 231-OEC cells. In total, 47 upregulated genes and 74 down-regulated genes were identified. Ten of 47 upregulated genes were selected to be further verified in 231-OE6 and 231-OEC cells by Real-time PCR, and nine of them were verified to be upregulated (Fig. 2b) . GALNT14, which is an O-glycosyltransferase, was one of the upregulated genes (Fig. 2b) . The upregulation of GALNT14 by Osx was further demonstrated by western blot analysis. As shown in Fig. 2c, GALNT14 was upregulated in 231-OE6 cells and down-regulated in 231-KD2 cells compared with their corresponding control cells. These data revealed that GALNT14 was a target gene of Osx. To further determine the relationship between Osx and GALNT14 expression in vivo, we implanted 231-OE6 and 231-KD2 cells, as well as their corresponding control cells, into the mammary fad pads of nude mice to establish the orthotopic transplantation model. The results of immunohistochemical analysis showed that the GALNT14 expression level was increased in tumour tissues formed by 231-OE6 cells compared with that formed by 231-OEC cells (Fig. 2d) . By contrast, the GALNT14 expression level was decreased in tumour tissues formed by 231-KD2 cells compared with that formed by 231-KDC cells (Fig. 2d) . These results were consistent with the results in vitro. Additionally, we examined the protein expression of Osx and GALNT14 in 115 human breast cancer specimens by immunohistochemical analysis. Fig. 3 . Osx decreases the chemosensitivity of breast cancer cells by upregulating GALNT14. (a) siRNAs specific to GALNT14 and the control (NC) were transiently transfected into MDA-MB-231 cells, respectively. GALNT14 protein was detected by western blot analysis. β-Actin served as an internal control. The 64-kDa blot of GALNT14 and 42-kDa blot of β-actin were cropped from the same gel and were run under the same experimental conditions. The fold change of KD vs. control was calculated after quantification and was presented above each blot. (b) GALNT14 siRNA-2 and its control (NC) were transiently transfected into 231-OE6 cells, and the GALNT14 expression plasmid (RK1-GALNT14) and its control (RK1) were transiently transfected into 231-KD2 cells. GALNT14 protein was detected by western blot analysis. β-Actin served as the loading control. The 64-kDa blot of GALNT14 and 42-kDa blot of β-actin were cropped from the same gel and were run under the same experimental conditions. The fold change of KD or OE vs. control was calculated after quantification and was presented above each blot. (c and d) GALNT14 siRNA-2 and NC were transfected into 231-OE6 cells, respectively. The RK1-GALNT14 expression plasmid and RK1 were transfected into 231-KD2 cells. Next, the transfected cells were treated with various concentrations of dox for 36 h. The inhibition rates of cells were analysed by the MTT assay (left), and the IC50 was calculated (right). (e and f) GALNT14 siRNA-2 and NC were transfected into 231-OE6 cells. The RK1-GALNT14 expression plasmid and RK1 were transfected into 231-KD2 cells. Next, the transfected cells were treated with various concentrations of pax for 36 h. The inhibition rates of cell viabilities were analysed by the MTT assay (left), and the IC50 was calculated (right). The results are the means ± SD of three independent experiments performed in triplicate. * p<0.05, ** p<0.01 and *** p<0.001. Fig. 2e shows the high and low expression of Osx and GALNT14 in human breast cancer tissues. Together, these data revealed that GALNT14 was a target gene of Osx.
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Osx decreases the chemosensitivity of breast cancer cells by upregulating GALNT14
Accumulating evidence has suggested that GALNT14 is an important regulator of chemosensitivity in tumour treatment. Therefore, we hypothesized that Osx may exert its function of decreasing the chemosensitivity of breast cancer cells by upregulating GALNT14. To test this hypothesis, we first synthesized the siRNAs specific to GALNT14 and constructed the expression plasmid of GALNT14. As shown in Fig. 3a , all three RNAi targets had higher interference efficiency. Next, we examined the inhibition rates of cells after transfecting GALNT14 siRNA-2 into 231-OE6 cells and the RK1-GALNT14 expression plasmid into 231-KD2 cells accompanied by the treatment of dox or pax. Fig. 3b shows the expression level of GALNT14 after GALNT14 siRNA-2 and RK1-GALNT14 expression plasmid transfection. Fig. 3c shows that the knockdown of GALNT14 recovered the decreased chemosensitivity of cells to dox by Osx overexpression, accompanied by a decreased IC50. Conversely, the overexpression of GALNT14 in 231-KD2 cells abrogated the increased chemosensitivity to dox by Osx knockdown, accompanied by an increased IC50 (Fig. 3d) . Similar results were observed in the cells transfected with GALNT14 siRNA-2 or the RK1-GALNT14 expression plasmid followed by pax treatment (Fig. 3e, f) . Taken together, these data suggest that Osx decreases the chemosensitivity of breast cancer cells, at least in part, by upregulating GALNT14 expression.
Osx enhances the anti-apoptosis of breast cancer cells by upregulating GALNT14
Next, we wondered whether the decrease in the chemosensitivity in breast cancer cells caused by Osx was associated with the changes in the anti-apoptosis ability of the cells. The results of the Hoechst staining assay showed that the percentage of apoptotic cells was markedly reduced in dox/pax-treated 231-OE6 cells compared with dox/pax-treated 231-OEC cells, whereas the percentage of apoptotic cells was markedly increased in dox/ pax-treated 231-KD2 cells compared with dox/pax-treated 231-KDC cells (Fig. 4a, b) . Furthermore, we examined the expression of anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bax and found that Bcl-2 was obviously increased in 231-OE6 cells and decreased in 231-KD2 cells compared with their corresponding control cells (Fig. 4c) . By contrast, Bax was obviously decreased in 231-OE6 cells and increased in 231-KD2 cells (Fig. 4c) . Taken together, these data indicate that Osx decreases the chemosensitivity of MDA-MB-231 cells through enhancing their anti-apoptosis ability. Accordingly, the percentage of apoptotic cells was significantly increased in dox-treated 231-OE6 cells transfected with GALNT14 siRNA-2 and decreased in dox-treated 231-KD2 cells transfected with the RK1-GALNT14 expression plasmid (Fig. 4d) . Similar results were observed in pax-treated 231-OE6 cells transfected with GALNT14 siRNA-2 and in pax-treated 231-KD2 cells transfected with the RK1-GALNT14 expression plasmid (Fig. 4e) . Moreover, the expression of Bcl-2 was decreased in 231-OE6 cells with GALNT14 knockdown and increased in 231-KD2 cells with GALNT14 overexpression compared with their corresponding control cells (Fig. 4f) . By contrast, the expression of Bax was increased in 231-OE6 cells with GALNT14 knockdown and decreased in 231-KD2 cells with GALNT14 overexpression compared with their corresponding control cells (Fig. 4f) . Together, these results suggest that Osx may decrease the chemosensitivity through enhancing the anti-apoptosis ability of breast cancer cells, and GALNT14 is involved in this process.
Clinical significance of GALNT14 expression
In the analysis of a 129-member tissue microarray (TMA), the GALNT14 expression level was expressed at a low level in 46 cases (35.7%) and at a high level in 83 tumours (64.3%). To determine the contribution of GALNT14 to breast cancer progression, we performed univariate analysis between GALNT14 and clinicopathological factors. As shown in Table 3 , the expression of GALNT14 was not significantly associated with the ER status and PR status (P>0.05). However, the GALNT14 expression level was significantly associated with HER2 status (P=0.038). Moreover, GALNT14 expression was correlated with the clinical stages of breast cancer (Fig. 5a ) and disease-free survival (DFS) rate significantly (P=0.029) (Fig. 5b) .
Discussion
The decrease in chemosensitivity is a large obstacle in the treatment of various types of cancers, including breast cancer [32] . As a key regulator of osteoblast differential and bone Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry formation, Osx has been reported to be involved in the progression of kidney, lung and breast cancer, although its function is largely unknown in cancer. In the present study, we defined an important role of Osx in chemosensitivity through regulating GALNT14, eventually affecting the apoptosis in breast cancer cells. Chemotherapy is the most important method for the treatment of cancer. The chemotherapy response in various cancer patients is frequently compromised by drug insensitivity, which eventually leads to treatment failure [33, 34] . Numerous genes associated with the drug sensitivity of chemotherapy have been identified [35] . The molecular mechanisms of drug insensitivity are associated with both genetic and epigenetic changes, including drug-induced mutations, cell cycle-and apoptosis-associated genes, histone modifications and DNA methylation [36] . In this study, we revealed that Osx, as a key transcription factor in osteoblast differentiation and bone formation, played an important role in the regulation of chemosensitivity in breast cancer cells, expanding our understanding of the mechanisms of tumour chemosensitivity.
The induction of apoptosis in cancer cells is expedient in the prevention of cancer [37] . Cancer cells possess the ability to evade apoptosis, rendering cytotoxic drugs ineffective, an activity that is considered one of the challenges in cancer treatment. Chemotherapeutics induce cancer cells to undergo apoptosis through different pathways [38] . GALNT14 shows a strong restraint to the sensitivity of the proapoptotic ligand Apo2L/TRAIL in pancreatic carcinoma, non-small cell lung cancer and melanoma [39] . The expression of GALNT14 appeared to be a better predictor of TRAIL sensitivity. It has been suggested that verifying the expression of GALNT14 may be used as a strategy to clarify patients who are more likely to benefit from chemotherapy [40, 41] . Here, we demonstrated that GALNT14 was regulated by Osx and was at least partly responsible for the decrease in chemosensitivity caused by Osx in breast cancer cells. Moreover, we confirmed that Osx decreased the chemosensitivity by enhancing the anti-apoptosis of breast cancer cells. In the clinical sample analysis, we found that GALNT14 expression was significantly associated with HER2 status in human breast cancer tissues. However, it remains to be elucidated the significance of the correlation between GALNT14 expression and HER2 status in breast cancer.
Conclusion
Our results showed that Osx decreased the chemosensitivity of breast cancer cells by upregulating the expression of GALNT14, which eventually suppressed the apoptosis of breast cancer cells. This newly identified Osx/GALNT14 link may provide a target to improve the chemosensitivity of breast cancer.
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